Acadia Pharma (ACAD)
24.96
-0.47 (1.85%)
Upcoming Events
Latest Headlines
Acadia Pharmaceuticals (ACAD) PT Raised to $36 at BMO Capital
July 21, 2026 7:36 AM - StreetInsider
Acadia Pharmaceuticals (ACAD) PT Raised to $25 at Stifel
July 20, 2026 4:25 PM - StreetInsider
Mizuho n Acadia Pharmaceuticals (ACAD): 'we view risk/reward as skewed significantly to the upside'
July 20, 2026 12:25 PM - StreetInsider
FDA grants fast track status to Acadia drug for Alzheimer's psychosis
July 20, 2026 9:05 AM - StreetInsider
Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis
July 20, 2026 9:05 AM - BizWire
Acadia Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 4, 2026
July 15, 2026 4:05 PM - BizWire
Acadia Pharmaceuticals (ACAD) PT Raised to $36 at RBC Capital
July 7, 2026 7:55 AM - StreetInsider
Acadia Pharmaceuticals Appoints Carl Segerstrom as Chief People Officer
July 6, 2026 9:04 AM - BizWire
H.C. Wainwright Reiterates Buy Rating on Acadia Pharmaceuticals (ACAD)
June 30, 2026 6:44 AM - StreetInsider
Form 4 ACADIA PHARMACEUTICALS For: Jun 26 Filed by: Kihara James
June 29, 2026 6:00 PM - SEC Filing
Acadia Pharmaceuticals (ACAD) PT Raised to $37 at Deutsche Bank
June 29, 2026 7:20 AM - StreetInsider
Acadia Pharmaceuticals (ACAD) PT Raised to $36 at Canaccord
June 29, 2026 6:49 AM - StreetInsider
Mizuho Reiterates Outperform Rating on Acadia Pharmaceuticals (ACAD)
June 29, 2026 6:41 AM - StreetInsider
Acadia Pharma (ACAD) call put ratio 6.8 calls to 1 put with a focus on July 25 calls
June 29, 2026 6:03 AM - StreetInsider
Acadia Pharmaceuticals (ACAD) PT Raised to $35 at Citi, Opens 90-Day Upside CW
June 29, 2026 3:57 AM - StreetInsider
Form 144 ACADIA PHARMACEUTICALS Filed by: Kihara James
June 26, 2026 3:10 PM - SEC Filing
Oppenheimer Reiterates Perform Rating on Acadia Pharmaceuticals (ACAD)
June 26, 2026 12:33 PM - StreetInsider
Baird Reiterates Outperform Rating on Acadia Pharmaceuticals (ACAD)
June 26, 2026 10:51 AM - StreetInsider
Mizuho Reiterates Outperform Rating on Acadia Pharmaceuticals (ACAD)
June 26, 2026 8:09 AM - StreetInsider
EU panel backs Acadia's Rett syndrome drug trofinetide for approval
June 26, 2026 6:49 AM - StreetInsider
DAYBU® (trofinetide) Recommended for Approval in the European Union by CHMP
June 26, 2026 6:49 AM - BizWire
Form S-8 ACADIA PHARMACEUTICALS
June 10, 2026 4:06 PM - SEC Filing
Form 4 ACADIA PHARMACEUTICALS For: May 29 Filed by: Baker Brothers Life Sciences LP
June 2, 2026 4:33 PM - SEC Filing
Form 4 ACADIA PHARMACEUTICALS For: May 29 Filed by: HARRIGAN EDMUND
June 1, 2026 6:00 PM - SEC Filing
Form 4 ACADIA PHARMACEUTICALS For: May 29 Filed by: Ndu Adora
June 1, 2026 6:00 PM - SEC Filing
Form 4 ACADIA PHARMACEUTICALS For: May 29 Filed by: GAROFALO ELIZABETH A.
June 1, 2026 6:00 PM - SEC Filing
Form 4 ACADIA PHARMACEUTICALS For: May 29 Filed by: Daly James M
June 1, 2026 6:00 PM - SEC Filing
Form 4 ACADIA PHARMACEUTICALS For: May 29 Filed by: Brege Laura
June 1, 2026 6:00 PM - SEC Filing
Form 4 ACADIA PHARMACEUTICALS For: May 29 Filed by: Poole Jonathan
June 1, 2026 6:00 PM - SEC Filing
Form 8-K ACADIA PHARMACEUTICALS For: May 29
May 29, 2026 4:06 PM - SEC Filing
Form 4 ACADIA PHARMACEUTICALS For: May 26 Filed by: Kihara James
May 27, 2026 6:00 PM - SEC Filing
Form 144 ACADIA PHARMACEUTICALS Filed by: Kihara James
May 26, 2026 4:06 PM - SEC Filing
Canaccord Reiterates Buy Rating on Acadia Pharmaceuticals (ACAD)
May 7, 2026 6:29 AM - StreetInsider
Form 10-Q ACADIA PHARMACEUTICALS For: Mar 31
May 7, 2026 6:06 AM - SEC Filing
Form 8-K ACADIA PHARMACEUTICALS For: May 06
May 6, 2026 4:51 PM - SEC Filing
Acadia Pharma (ACAD) Misses Q1 EPS by 3c ; Offers Guidance
May 6, 2026 4:07 PM - StreetInsider
Acadia Pharmaceuticals Reports First Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance
May 6, 2026 4:05 PM - BizWire
Form 4 ACADIA PHARMACEUTICALS For: May 01 Filed by: Kihara James
May 5, 2026 6:00 PM - SEC Filing
Form 4 ACADIA PHARMACEUTICALS For: May 01 Filed by: Schneyer Mark C.
May 5, 2026 6:00 PM - SEC Filing
Form 8-K ACADIA PHARMACEUTICALS For: Apr 27
May 1, 2026 9:19 AM - SEC Filing
Acadia Pharmaceuticals Announces Planned Year-End Retirement of Elizabeth H.Z. Thompson, Ph.D., Head of Research and Development, Following a Distinguished Career
April 30, 2026 4:05 PM - BizWire
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
April 28, 2026 4:05 PM - BizWire
Form SCHEDULE 13G ACADIA PHARMACEUTICALS Filed by: VANGUARD PORTFOLIO MANAGEMENT LLC
April 28, 2026 3:54 PM - SEC Filing
Acadia Pharmaceuticals (ACAD) PT Lowered to $38 at Needham
April 24, 2026 8:44 AM - StreetInsider
Form ARS ACADIA PHARMACEUTICALS For: Dec 31
April 24, 2026 6:02 AM - SEC Filing
Form DEF 14A ACADIA PHARMACEUTICALS For: May 29
April 24, 2026 6:02 AM - SEC Filing
Full Article List
